Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review
Open Access
- 18 December 2009
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 451
- https://doi.org/10.1186/1471-2407-9-451
Abstract
In Europe, extracts from Viscum album (VA-E), the European white-berry mistletoe, are widely used to treat patients with cancer.This publication has 32 references indexed in Scilit:
- Wirksamkeit und Unbedenklichkeit einer Langzeitbehandlung von Melanompatienten mit einem Mistelpräparat (Iscador)Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine, 2007
- Final results of the EORTC 18871/DKG 80-1 randomised phase III trial: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasisPublished by Elsevier ,2004
- Is breast cancer survival improving?Cancer, 2003
- Mistletoe for cancer?International Journal of Cancer, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Beeinflusst die Misteltherapie die Abwehr epithelialer Tumoren? Eine kritische immunologische AnalyseDeutsche Medizinische Wochenschrift (1946), 2001
- Mistletoe Therapy in OncologyPublished by Wiley ,2001
- Differences in the apoptosis-inducing properties of Viscum album L. extractsAnti-Cancer Drugs, 1997
- Review papers : The statistical basis of meta-analysisStatistical Methods in Medical Research, 1993
- Is Carcinoma of the Gallbladder a Curable Lesion?Annals of Surgery, 1982